Región del Biobío
Este organismo compró $3.659.110.717 en 4.552 órdenes de compra , sobre todo en Salud, servicios sanitarios y alimentación / Medicina y servicios de salud / Evaluaciones de salud individuales y le compró principalmente a Abbott Laboratories de Chile Ltda..
236 meses con data · color por monto (sqrt scale)
| Año | Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sep | Oct | Nov | Dic | Total año |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
| $172,5 M |
| 2025 | $298,4 M |
| 2024 | $260,6 M |
| 2023 | $383,1 M |
| 2022 | $442,8 M |
| 2021 | $332,4 M |
| 2020 | $333,1 M |
| 2019 | $207,7 M |
| 2018 | $190,8 M |
| 2017 | $152,5 M |
| 2016 | $118,6 M |
| 2015 | $164,6 M |
| 2014 | $158,1 M |
| 2013 | $93,9 M |
| 2012 | $62,3 M |
| 2011 | $71,1 M |
| 2010 | $74,3 M |
| 2009 | $68,6 M |
| 2008 | $45,7 M |
| 2007 | $26,6 M |
| 2006 | $1,5 M |
236 períodos con data
Fuente: Agregaciones mensuales sobre OCs ingeridas
10 contrapartes
Fuente: Tabla top_contrapartes_comprador
| Código | Fecha | Proveedor | Estado | Monto |
|---|---|---|---|---|
| 3606-252-SE23 | 31-12-2023 | Oscar Orlando Garrido Villagran | Aceptada | $17.400.000 |
| 3606-250-AG23 | 14-12-2023 | Opko Chile S.A. | Aceptada | $85.085 |
| 3606-251-AG23 | 14-12-2023 | Opko Chile S.A. | Aceptada | $642.600 |
| 3606-237-SE23 | 07-12-2023 | Pharmaxpress SpA | Aceptada | $489.495 |
| 3606-238-SE23 | 07-12-2023 | Novo Nordisk Farmaceutica Limitada | Aceptada | $640.458 |
| 3606-239-SE23 | 07-12-2023 | Opko Chile S.A. | Aceptada | $1.429.785 |
| 3606-240-SE23 | 07-12-2023 | Arama Natural Products Distribuidora Limitada | Aceptada | $406.980 |
| 3606-241-SE23 | 07-12-2023 | Novofarma Service S.A. | Aceptada | $1.016.593 |
| 3606-242-SE23 | 07-12-2023 | Goat Pharma SpA | Aceptada | $348.730 |
| 3606-243-SE23 | 07-12-2023 | Farmaceutica Caribean SpA | Aceptada | $1.092.042 |
| 3606-244-SE23 | 07-12-2023 | Instituto Sanitas S.A. | Aceptada | $135.660 |
| 3606-245-SE23 | 07-12-2023 | Etex Farmaceutica Limitada | Aceptada | $333.117 |
| 3606-246-SE23 | 07-12-2023 | Glaxosmithkline Chile Farmaceutica Limitada | Aceptada | $1.021.428 |
| 3606-247-SE23 | 07-12-2023 | Drogueria Global Pharma SpA | Aceptada | $470.225 |
| 3606-248-SE23 | 07-12-2023 | Abbott Laboratories de Chile Ltda. | Aceptada | $12.276.516 |
| 3606-249-SE23 | 07-12-2023 | Novofarma Service S.A. | Aceptada | $6.613.648 |
| 3606-227-AG23 | 06-12-2023 | Eduardo Awad Manzur | Aceptada | $460.887 |
| 3606-228-SE23 | 06-12-2023 | Salcobrand S.A. | Aceptada | $258.416 |
| 3606-229-SE23 | 06-12-2023 | Laboratorio Chile S.A. | Aceptada | $278.520 |
| 3606-230-SE23 | 06-12-2023 | Scm Pharma SpA | Aceptada | $1.154.488 |
| 3606-231-SE23 | 06-12-2023 | Galenicum Health Chile SpA | Aceptada | $329.475 |
| 3606-232-SE23 | 06-12-2023 | Megalabs Chile S.A. | Aceptada | $456.672 |
| 3606-233-SE23 | 06-12-2023 | Abbvie Productos Farmaceuticos Limitada | Aceptada | $200.937 |
| 3606-234-SE23 | 06-12-2023 | Laboratorios Andromaco S.A. | Aceptada | $683.178 |
| 3606-235-SE23 | 06-12-2023 | Ethon Pharmaceuticals Ltda. | Aceptada | $75.898 |
| 3606-236-SE23 | 06-12-2023 | Laboratorios Recalcine S.A. | Aceptada | $145.594 |
| 3606-202-SE23 | 01-12-2023 | Laboratorio Chile S.A. | Aceptada | $328.440 |
| 3606-203-SE23 | 01-12-2023 | Opko Chile S.A. | Aceptada | $1.797.495 |
| 3606-204-SE23 | 01-12-2023 | Ascend Laboratories SpA | Aceptada | $1.198.092 |
| 3606-205-SE23 | 01-12-2023 | Importadora y Comercializadora Re-Med SpA | Aceptada | $113.050 |
